Back to company

DECHRA VETERINARY PRODUCTS A/S: Financial statements 2023

CVR: 10114241

DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,513,140,000 and a net result of DKK 129,704,000 compared with DKK 157,581,000 the year before. That is an increase of 6.1% compared with the year before. The profit margin was 5.2%. Equity amounted to DKK 688,900,000. The solvency ratio was 50.8%. The company had 110 employees in the financial year.

Revenue
2,513,140,000 kr.
Gross Profit
238,874,000 kr.
Profit/Loss
129,704,000 kr.
Equity
688,900,000 kr.
Total Assets
1,356,395,000 kr.
Employees
110

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20232.5 mia.238.9 mio.129.7 mio.688.9 mio.110
20222.4 mia.255.8 mio.157.6 mio.560.4 mio.108
20212.1 mia.192.2 mio.98.3 mio.403.1 mio.98
20201.6 mia.112 mio.23.3 mio.302.8 mio.91
20191.4 mia.193.6 mio.96.5 mio.555.8 mio.76

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Paul Nicholas Sandland joins the board of DECHRA VETERINARY PRODUCTS A/SNov 27, 2023

As of November 27, 2023, Paul Nicholas Sandland has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.

Anthony Gerard Griffin leaves the board of DECHRA VETERINARY PRODUCTS A/SNov 27, 2023

As of November 27, 2023, Anthony Gerard Griffin has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.

About DECHRA VETERINARY PRODUCTS A/S

DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The company is owned by Dechra Pharmaceuticals Limited. The company has 78 employees. In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity amounted to DKK 571,636,000.